Literature DB >> 666100

Reversible respiratory disease in beryllium workers.

N L Sprince, D J Kanarek, A L Weber, R I Chamberlin, H Kazemi.   

Abstract

A medical and environmental survey was carried out in a beryllium extraction and processing plant in 1971, and a follow-up study was done in 1974. Peak air concentrations of beryllium of as much as 50 times the accepted peak limit value were found in the plant in 1971. Radiographic changes of interstitial disease were found in 31 workers, hypoxemia was found in 20, and in 11 workers a combination of hypoxemia and radiographic changes of interstitial disease was seen. Follow-up in 1974 showed that air concentrations had all decreased significantly, mainly because of improvements in engineering and ventilation in the plant. Improvement in hypoxemia and decreased alveolar-arterial O2 tension difference at rest ([A-a]DO2) were noted in 13 of the 20 men who had hypoxemia in 1971 and were available for follow-up. In addition, radiographic abnormalities of interstitial disease were reversed in some workers. Our results suggest that improvement in gas exchange and radiographic findings of interstitial disease occurs when peak air concentrations of beryllium are decreased. Our approach in combining environmental and medical screening in workers exposed to beryllium enabled us to identify persons with early changes, to detect reversible abnormalities, and to correlate air concentrations with the medical status of workers.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 666100     DOI: 10.1164/arrd.1978.117.6.1011

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  8 in total

Review 1.  Clinical application of beryllium lymphocyte proliferation testing.

Authors:  Barbara P Barna; Daniel A Culver; Belinda Yen-Lieberman; Raed A Dweik; Mary Jane Thomassen
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

2.  Scintigraphy with J001X, a Klebsiella membrane glycolipid, for the early diagnosis of chronic berylliosis: results from an experimental model.

Authors:  P Diot; A Le Pape; D Nolibe; G Normier; H Binz; J P Revillard; G Lasfargues; M Lavandier; E Lemarié
Journal:  Br J Ind Med       Date:  1992-05

3.  Current treatment of chronic beryllium disease.

Authors:  Akshay Sood
Journal:  J Occup Environ Hyg       Date:  2009-12       Impact factor: 2.155

4.  Chest wall shrapnel-induced beryllium-sensitization and associated pulmonary disease.

Authors:  E Fireman; A Bar Shai; Y Lerman; M Topilsky; P D Blanc; L Maier; L Li; S Chandra; J M Abraham; I Fomin; G Aviram; J L Abraham
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2012-10       Impact factor: 0.670

5.  Simultaneous testing of immunological sensitization to multiple antigens in sarcoidosis reveals an association with inorganic antigens specifically related to a fibrotic phenotype.

Authors:  E Beijer; R Kraaijvanger; C Roodenburg; J C Grutters; B Meek; M Veltkamp
Journal:  Clin Exp Immunol       Date:  2020-10-06       Impact factor: 4.330

Review 6.  The natural history of beryllium sensitization and chronic beryllium disease.

Authors:  L S Newman; J Lloyd; E Daniloff
Journal:  Environ Health Perspect       Date:  1996-10       Impact factor: 9.031

7.  Immunoreactivity to metal and silica associates with sarcoidosis in Dutch patients.

Authors:  E Beijer; B Meek; X Bossuyt; S Peters; R C H Vermeulen; H Kromhout; M Veltkamp
Journal:  Respir Res       Date:  2020-06-08

Review 8.  Sarcoidosis: An Occupational Disease?

Authors:  L Christine Oliver; Andrew M Zarnke
Journal:  Chest       Date:  2021-06-05       Impact factor: 9.410

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.